Diagnostic Errors are Leading Cause of Medical Malpractice Claims Says Report
Story Highlights A recent report by Coverys Inc. found that diagnostic errors were the most common reason for medical malpractice claims from 2013 to 2017. An estimated 40,000 to 80,000 people die each year from diagnostic failures in American hospitals. Most medical diagnostic errors occur in outpatient settings and emergency departments. A recent report released by an […]
Pfizer and BioNTech Begin Human Clinical Trials of COVID-19 Vaccine in U.S.
Pfizer, Inc. of New York and BioNTech SE of Mainz, Germany have announced that human clinical trials for an experimental COVID-19 vaccine they have co-developed, known as BNT162, have begun in the United States.1 As part of a global clinical development program, the first human subjects in the U.S. Phase I and Phase clinical II […]
Autism Numbers Increase by 8.5 Percent in U.S.
According to the U.S. Centers for Disease Control and Prevention (CDC), the number of children diagnosed with autism in the United States continues to increase. In a report published on Mar. 27, 2020, the CDC estimated the prevalence of autism spectrum disorder (ASD) in the country is now 1 in 54 children—up from 1 in […]
Live Tuberculosis “Vaccine” Being Tested as a Treatment for COVID-19 Infections
Story Highlights Researchers at Texas A&M University and five other academic institutions have begun a phase 4 clinical trial re-purposing a live attenuated tuberculosis vaccine to treat COVID-19. The researchers believe that the TICE® BCG vaccine, which is licensed to prevent and treat bladder cancer, may help mitigate the severity of COVID-19. The research team […]
Health Officials Launch Mobile App to Pre-Register Chicagoans for COVID-19 Vaccine
Story Highlights The Chicago Department of Public Health has launched a website and a mobile device application encouraging residents to pre-register to get for a future COVID-19 vaccine. Chicago’s Mayor said the electronic database will be used to prepare plans for mass vaccination of all residents after a COVID-19 vaccine is licensed by the FDA […]
GSK and Sanofi COVID-19 Vaccine Produced in Insect Cells with Squalene Adjuvant
Story Highlights GlaxoSmithKline and Sanofi Pasteur are partnering to develop an experimental COVID-19 vaccine. The two global vaccine manufacturers are using existing recombinant DNA vaccine technology and a squalene adjuvant for their COVID-19 vaccine. Clinical trials are scheduled to begin in the second half of 2020 and, if successful, the vaccine will be available in […]